Data / Form D filings / Genialis, Inc.
Genialis, Inc.: Form D filings
Genialis, Inc., a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on December 31, 2025, reports $700,000 sold of a $3 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 68 HARRISON AVE #605, PMB 29417, Boston, MA, 02111
- Phone
- (617) 237-0085
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1948756
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | New notice | $3,000,000 | $700,000 | $2,300,000 | 2 | Dec 17, 2025 | sec.gov |
| Jan 31, 2023 | New notice | $13,894,258 | $11,423,253 | $2,471,005 | 10 | Jan 19, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ita Lu | Director | |
| Cedric Hermann Odje | Director | |
| Elia Hermann Stupka | Director | |
| Krista McKerracher | Director | |
| Miha Stajdohar | Executive Officer, Director | |
| Rafael Rosengarten | Executive Officer, Director | |
| Luka Ausec | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Genialis, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.